Literature DB >> 18726170

High prevalence of hepatitis B virus pre-S mutation and its association with hepatocellular carcinoma in Qidong, China.

Zhigang Cao1, Xin Bai, Xia Guo, Yan Jin, Gengsun Qian, Hong Tu.   

Abstract

We investigated the frequency and the clinical relevance of hepatitis B virus (HBV) pre-S mutations in Qidong, China. The results showed HBV pre-S mutants were detected in 48.4% (47/97) of patients with HBV infection. Both pre-S deletion and pre-S2 start codon mutations were more frequently found in HCC than in CH patients (51.1% vs. 18.0%, P < 0.01 and 21.2% vs. 8.0%, P = 0.06). In most cases, pre-S mutants coexisted with the wild-type HBV strain. Longitudinal observation clearly revealed that in four of five cases, HBV deletion mutants emerged during the course of HBV infection and eventually became the predominant or exclusive viral population at the stage of HCC. Thus, it was concluded that HBV pre-S mutations were highly prevalent and closely related to HCC in Qidong. Our results also provided direct evidence that pre-S deletion mutants were not acquired from the beginning of infection but arose de novo during the progression of liver disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18726170     DOI: 10.1007/s00705-008-0176-9

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  13 in total

1.  Pre-s mutation is a significant risk factor for hepatocellular carcinoma development: a long-term retrospective cohort study.

Authors:  Dong Hyun Sinn; Moon Seok Choi; Geum-Youn Gwak; Yong-Han Paik; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo
Journal:  Dig Dis Sci       Date:  2012-09-30       Impact factor: 3.199

2.  Association of novel mutations and haplotypes in the preS region of hepatitis B virus with hepatocellular carcinoma.

Authors:  Jia-Xin Xie; Jun Zhao; Jian-Hua Yin; Qi Zhang; Rui Pu; Wen-Ying Lu; Hong-Wei Zhang; Hong-Yang Wang; Guang-Wen Cao
Journal:  Front Med China       Date:  2010-11-19

Review 3.  Clinical significance of hepatitis B surface antigen mutants.

Authors:  Nicola Coppola; Lorenzo Onorato; Carmine Minichini; Giovanni Di Caprio; Mario Starace; Caterina Sagnelli; Evangelista Sagnelli
Journal:  World J Hepatol       Date:  2015-11-28

4.  Quantitative evaluation of hepatitis B virus mutations and hepatocellular carcinoma risk: a meta-analysis of prospective studies.

Authors:  Yang Yang; Jiang-Wei Sun; Long-Gang Zhao; Freddie Bray; Yong-Bing Xiang
Journal:  Chin J Cancer Res       Date:  2015-10       Impact factor: 5.087

5.  Novel approach to identifying the hepatitis B virus pre-S deletions associated with hepatocellular carcinoma.

Authors:  Zhi-Mei Zhao; Yan Jin; Yu Gan; Yu Zhu; Tao-Yang Chen; Jin-Bing Wang; Yan Sun; Zhi-Gang Cao; Geng-Sun Qian; Hong Tu
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

6.  Hepatitis B virus pre-S2 start codon mutations in Indonesian liver disease patients.

Authors:  Andi Utama; Marlinang Diarta Siburian; Ismail Fanany; Mariana Destila Bayu Intan; Rama Dhenni; Tri Shinta Kurniasih; Syafruddin A R Lelosutan; Wenny Astuti Achwan; Nasrul Zubir; Benyamin Lukito; Irawan Yusuf; Laurentius Adrianus Lesmana; Ali Sulaiman
Journal:  World J Gastroenterol       Date:  2012-10-14       Impact factor: 5.742

7.  Lost Small Envelope Protein Expression from Naturally Occurring PreS1 Deletion Mutants of Hepatitis B Virus Is Often Accompanied by Increased HBx and Core Protein Expression as Well as Genome Replication.

Authors:  Shuwen Fu; Jing Zhang; Quan Yuan; Qianru Wang; Qiang Deng; Jisu Li; Ningshao Xia; Yongxiang Wang; Yumei Wen; Shuping Tong
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

8.  A high variability of mixed infections and recent recombinations of hepatitis B virus in Laos.

Authors:  Iris E Andernach; Prapan Jutavijittum; Bounthome Samountry; Amnat Yousukh; Te Thammavong; Judith M Hübschen; Claude P Muller
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

9.  Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.

Authors:  Shijian Liu; Hongwei Zhang; Chunying Gu; Jianhua Yin; Yongchao He; Jiaxin Xie; Guangwen Cao
Journal:  J Natl Cancer Inst       Date:  2009-07-02       Impact factor: 13.506

10.  Qidong hepatitis B virus infection cohort: a 25-year prospective study in high risk area of primary liver cancer.

Authors:  Taoyang Chen; Gengsun Qian; Chunsun Fan; Yan Sun; Jinbing Wang; Peixin Lu; Xuefeng Xue; Yan Wu; Qinan Zhang; Yan Jin; Yiqian Wu; Yu Gan; Jianquan Lu; Thomas W Kensler; John D Groopman; Hong Tu
Journal:  Hepatoma Res       Date:  2018-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.